The Latest in IT Security

Modified measles virus destroys cancer in early clinical trial

19
May
2014

Promising early results from a clinical trial at the Mayo Clinic out this week suggest that a modified version of the measles virus can be used to target cancer cells and put the condition into remission. Researchers intravenously delivered 10,000 times the typical dosage of measles vaccine to two women, 49- and 65-years-old, who had multiple myeloma, a rare cancer affecting white blood cells in bone marrow. The virus, which was modified to specifically target cancer cells, reduced or eliminated tumors in the two patients. The idea of using viruses to attack cancer isnt a new one — scientists have been studying the technique since the 1950s.

Comments are closed.

Categories

TUESDAY, MARCH 09, 2021
WHITE PAPERS

Mission-Critical Broadband – Why Governments Should Partner with Commercial Operators:
Many governments embrace mobile network operator (MNO) networks as ...

ARA at Scale: How to Choose a Solution That Grows With Your Needs:
Application release automation (ARA) tools enable best practices in...

The Multi-Model Database:
Part of the “new normal” where data and cloud applications are ...

Featured

Archives

Latest Comments